Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-30 @ 1:36 PM
Study NCT ID:
NCT00047567
Status:
TERMINATED
Last Update Posted:
2015-12-14
First Post:
2002-10-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open-label Adjunctive Zonisamide for Bipolar Disorder
Sponsor:
Elan Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ELN-345-509
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None